{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:44:00Z","timestamp":1791924240330,"version":"4.3.4"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>The study aimed to evaluate the effect of roflumilast on modulating TNF-\u03b1\/Caspase mediated cellular signals in cisplatin-induced nephrotoxicity in rats.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The rats (Male Wistar) were divided into five groups: normal control, disease control (cisplatin: 7 mg\/kg i.p.), and cisplatin + roflumilast (0.25, 0.5, and 1 mg\/kg b.w., p.o.). Cisplatin was administrated to rats on 0 day, and roflumilast treatment was started from the 6th\u201315th days. Blood and tissue were collected. Tissue was used to measure oxidative stress, such as malondialdehyde, superoxide dismutase, and catalase. Gene expression study involved real-time PCR of key genes linked with inflammation and apoptosis, i.e. Tnf-\u03b1, Tnfr1, Tnfr2, Fas, Nfkb, Casp3, Casp8, and Nrf2.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>Cisplatin showed decreased serum creatinine and urea, high albumin, and total protein. Cisplatin elevated the malondialdehyde and reduced superoxide dismutase and catalase activity. Cisplatin also attributed an overexpression of Tnf-\u03b1, Tnfr1, Tnfr2, Nfkb, Fas, Casp3, and Casp8, and a decrease in the Nrf2 gene. Roflumilast decreased creatinine and urea and increased albumin and total protein levels. Roflumilast also downregulated the expression of Tnf-\u03b1, Tnfr1, Tnfr2, Nfkb, Fas, Casp3, and Casp8 and upregulated the Nrf2 gene expression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Roflumilast manifested as a potential reno-protective agent against cisplatin-induced nephrotoxicity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpp\/rgae142","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T21:31:11Z","timestamp":1732138271000},"page":"308-320","source":"Crossref","is-referenced-by-count":6,"title":["Roflumilast mitigates cisplatin-induced nephrotoxicity by regulating TNF-\u03b1\/TNFR1\/TNFR2\/Fas\/Caspase mediated apoptosis and inflammatory signals"],"prefix":"10.1093","volume":"77","author":[{"given":"Priyal","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology , Changa, Anand, Gujarat 388421 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, L.M. College of Pharmacy , Ahmedabad, Gujarat 380009 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology , Changa, Anand, Gujarat 388421 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Chudasama","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Sat-Kaival Hospital Pvt. Ltd , Anand, Gujarat 388001 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Soni","sequence":"additional","affiliation":[{"name":"Department of Pathology, Muljibhai Patel Urological Hospital , Nadiad, Gujarat 387002 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4481-8296","authenticated-orcid":false,"given":"Samir","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Analysis, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology , Changa, Anand, Gujarat 388421 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5823-2264","authenticated-orcid":false,"given":"Manan","family":"Raval","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy and Phytochemistry, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology , Changa, Anand, Gujarat 388421 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"2025020305562733000_CIT0001","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"2025020305562733000_CIT0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.13005\/bpj\/1608","article-title":"Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin","volume":"12","author":"Aldossary","year":"2019","journal-title":"Biomed Pharmacol J"},{"key":"2025020305562733000_CIT0003","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ekir.2017.02.008","article-title":"Anticancer drug-induced acute kidney injury","volume":"2","author":"Izzedine","year":"2017","journal-title":"Kidney Int Rep"},{"key":"2025020305562733000_CIT0004","first-page":"1","article-title":"Critical analysis of protective role of plants against gentamicin induced nephrotoxicity","volume":"21","author":"Yadav","year":"2017","journal-title":"Indian J Environ Sci"},{"key":"2025020305562733000_CIT0005","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1039\/c4mt00238e","article-title":"Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin","volume":"6","author":"Eljack","year":"2014","journal-title":"Metallomics"},{"key":"2025020305562733000_CIT0006","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular mechanisms of resistance and toxicity associated with platinating agents","volume":"33","author":"Rabik","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"2025020305562733000_CIT0007","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41401-021-00620-9","article-title":"Natural products: potential treatments for cisplatin-induced nephrotoxicity","volume":"42","author":"Fang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"2025020305562733000_CIT0008","doi-asserted-by":"crossref","first-page":"15592","DOI":"10.1038\/srep15592","article-title":"Ancient Chinese formula Qiong-Yu-Gao protects against cisplatin-induced nephrotoxicity without reducing anti-tumor activity","volume":"5","author":"Teng","year":"2015","journal-title":"Sci Rep"},{"key":"2025020305562733000_CIT0009","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am J Med Sci"},{"key":"2025020305562733000_CIT0010","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jat.2818","article-title":"The peroxisome proliferator-activated receptor-\u03b3 agonist pioglitazone protects against cisplatin-induced renal damage in mice","volume":"34","author":"Jesse","year":"2014","journal-title":"J Appl Toxicol"},{"key":"2025020305562733000_CIT0011","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1046\/j.1523-1755.2003.00709.x","article-title":"Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death","volume":"63","author":"Tsuruya","year":"2003","journal-title":"Kidney Int"},{"key":"2025020305562733000_CIT0012","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1038\/s41598-019-40913-y","article-title":"Molecular dynamic simulations of oxidized skin lipid bilayer and permeability of reactive oxygen species","volume":"9","author":"Yadav","year":"2019","journal-title":"Sci Rep"},{"key":"2025020305562733000_CIT0013","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/toxsci\/kfm152","article-title":"Cisplatin, gentamicin, and p-aminophenol induce markers of endoplasmic reticulum stress in the rat kidneys","volume":"99","author":"Peyrou","year":"2007","journal-title":"Toxicol Sci"},{"key":"2025020305562733000_CIT0014","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0518-9","article-title":"Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity","volume":"26","author":"Volarevic","year":"2019","journal-title":"J Biomed Sci"},{"key":"2025020305562733000_CIT0015","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"key":"2025020305562733000_CIT0016","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/15569543.2020.1857772","article-title":"Role of renin blocker (Aliskiren) on Cisplatin induced-nephrotoxicity in rats","volume":"41","author":"Alshahrani","year":"2022","journal-title":"Toxin Rev"},{"key":"2025020305562733000_CIT0017","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.ki.5002242","article-title":"Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-\u03b1 produced by renal parenchymal cells","volume":"72","author":"Zhang","year":"2007","journal-title":"Kidney Int"},{"key":"2025020305562733000_CIT0018","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/COPD.S89849","article-title":"a review of its use in the treatment of COPD","volume":"6","author":"Wedzicha","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025020305562733000_CIT0019","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pupt.2010.03.011","article-title":"The preclinical pharmacology of roflumilast\u2013a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease","volume":"23","author":"Hatzelmann","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"2025020305562733000_CIT0020","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ki.2011.467","article-title":"Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure","volume":"81","author":"Zhong","year":"2012","journal-title":"Kidney Int"},{"key":"2025020305562733000_CIT0021","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/fcp.12711","article-title":"Roflumilast improves resolution of sepsis-induced acute kidney injury by retarding late phase renal interstitial immune cells infiltration and leakage in urinary sediments","volume":"36","author":"Gupta","year":"2022","journal-title":"Fundam Clin Pharmacol"},{"key":"2025020305562733000_CIT0022","doi-asserted-by":"publisher","first-page":"109583","DOI":"10.1016\/j.intimp.2022.109583","article-title":"Therapeutic treatment with phosphodiesterase-4 inhibitors alleviates kidney injury and renal fibrosis by increasing MMP-9 in a doxorubicin-induced nephrotoxicity mouse model","volume":"115","author":"Costa","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"2025020305562733000_CIT0023","doi-asserted-by":"publisher","first-page":"F940","DOI":"10.1152\/ajprenal.00079.2004","article-title":"Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4","volume":"287","author":"Cheng","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025020305562733000_CIT0024","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.21037\/jtd.2017.03.116","article-title":"Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases","volume":"9","author":"Kawamatawong","year":"2017","journal-title":"J Thorac Dis"},{"key":"2025020305562733000_CIT0025","doi-asserted-by":"publisher","first-page":"113836","DOI":"10.1016\/j.biopha.2022.113836","article-title":"Ajwa dates (Phoenix dactylifera L.) attenuate cisplatin-induced nephrotoxicity in rats via augmenting Nrf2, modulating NADPH oxidase-4 and mitigating inflammatory\/apoptotic mediators. Biomedicine &","volume":"156","author":"Abdelghffar","year":"2022","journal-title":"Pharmacotherapy"},{"key":"2025020305562733000_CIT0026","first-page":"3","article-title":"Center for drug evaluation and research application number: 022522Orig1s000 pharmacology review(s) 1","volume":"29","author":"Brown","year":"2011","journal-title":"Tertiary Pharmacol Rev"},{"key":"2025020305562733000_CIT0027","doi-asserted-by":"publisher","first-page":"108961","DOI":"10.1016\/j.biopha.2019.108961","article-title":"Nephroprotective activity of Combretum micranthum G. Don in cisplatin induced nephrotoxicity in rats: in-vitro, in-vivo and in-silico experiments","volume":"116","author":"Kpemissi","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2025020305562733000_CIT0028","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"2025020305562733000_CIT0029","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur J Biochem"},{"key":"2025020305562733000_CIT0030","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.2042-7158.2012.01470.x","article-title":"Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress","volume":"64","author":"Sultana","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"2025020305562733000_CIT0031","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"[13] Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol"},{"key":"2025020305562733000_CIT0032","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2025020305562733000_CIT0033","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/molecules28031302","article-title":"Nephroprotective effect of diosmin against cisplatin-induced kidney damage by modulating IL-1\u03b2, IL-6, TNF\u03b1, and renal oxidative damage","volume":"28","author":"Anwer","year":"2023","journal-title":"Molecules"},{"key":"2025020305562733000_CIT0034","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3390\/ijms21041242","article-title":"Cisplatin-induced skeletal muscle dysfunction: mechanisms and counteracting therapeutic strategies","volume":"21","author":"Conte","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025020305562733000_CIT0035","doi-asserted-by":"publisher","first-page":"17248","DOI":"10.1038\/s41598-021-96509-y","article-title":"Acacia hydaspica R. Parker ethyl-acetate extract abrogates cisplatin-induced nephrotoxicity by targeting ROS and inflammatory cytokines","volume":"11","author":"Afsar","year":"2021","journal-title":"Sci Rep"},{"key":"2025020305562733000_CIT0036","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/jphp.12990","article-title":"Oral deferiprone administration ameliorates cisplatin-induced nephrotoxicity in rats","volume":"70","author":"Makhdoumi","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"2025020305562733000_CIT0037","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update","volume":"86","author":"dos Santos","year":"2012","journal-title":"Arch Toxicol"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/2\/308\/60772199\/rgae142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/2\/308\/60772199\/rgae142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T05:56:34Z","timestamp":1738562194000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/77\/2\/308\/7905658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,11,20]]},"published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgae142","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,11,20]]}}}